Key result
Review summarizes current evidence on the diagnosis, treatment, and prognosis of concomitant VHD and cardiac amyloidosis.
Why the study?
While data on aortic stenosis and cardiac amyloidosis have expanded, evidence regarding mitral/tricuspid regurgitation and cardiac amyloidosis remains scarce despite high clinical relevance.
Design
Review article
Authors
Loading...
Diagnostic approaches need refinement in cardiac amyloidosis with valvular disease; leaves open key evidence gaps for mitral/tricuspid regurgitation.
This review highlights the clinical relevance and current understanding of the co-existence of cardiac amyloidosis and valvular heart disease, emphasizing the need for awareness of this dual pathology.
Duca et al. (2023) conducted a review in Cardiac amyloidosis and valvular heart disease. This review summarizes current evidence on the epidemiology, diagnosis, treatment, and prognosis of concomitant valvular heart disease and cardiac amyloidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: